Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond
Alberto Aimo, Giosafat Spitaleri, Dario Nieri, et al.
Cardiac failure review (2022) Vol. 8
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
Joshua J. Solomon, Sonye K. Danoff, Felix Woodhead, et al.
The Lancet Respiratory Medicine (2022) Vol. 11, Iss. 1, pp. 87-96
Closed Access | Times Cited: 127
Pulmonary inflammation and fibroblast immunoregulation: from bench to bedside
Mohamed A. Ghonim, David F. Boyd, Tim Flerlage, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 17
Open Access | Times Cited: 24
The mitigating effect of para‐hydroxycinnamic acid in bleomycin‐induced pulmonary fibrosis in mice through targeting oxidative, inflammatory and fibrotic pathways
Zeena Ayad Hussein, Ahmed R. Abu‐Raghif, Hayder Adnan Fawzi
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 135, Iss. 1, pp. 23-42
Closed Access | Times Cited: 14
Network Pharmacology-driven therapeutic interventions for Interstitial Lung Diseases using Traditional medicines: A Narrative Review
Megh Pravin Vithalkar, K. Sandra, Bharath Harohalli Byregowda, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113979-113979
Open Access | Times Cited: 1
Health position paper and redox perspectives – Bench to Bedside Transition for Pharmacological Regulation of NRF2 in Noncommunicable Diseases
Antonio Cuadrado, Eduardo Cazalla, Anders Bach, et al.
Redox Biology (2025), pp. 103569-103569
Open Access | Times Cited: 1
Pulmonary fibrosis: Emerging diagnostic and therapeutic strategies
Brintha Selvarajah, Manuela Platé, Rachel C. Chambers
Molecular Aspects of Medicine (2023) Vol. 94, pp. 101227-101227
Closed Access | Times Cited: 22
Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies
Hehua Guo, Jiazheng Sun, Siyu Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 21
Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation
Guangrui Chen, Jian Li, Huimeng Liu, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 753-753
Open Access | Times Cited: 18
Intra-articular sustained-release of pirfenidone as a disease-modifying treatment for early osteoarthritis
Xiaobo Zhu, Mingde Cao, Kejia Li, et al.
Bioactive Materials (2024) Vol. 39, pp. 255-272
Open Access | Times Cited: 5
Idiopathic Pulmonary Fibrosis: In Silico Therapeutic Potential of Doxycycline, Pirfenidone, and Nintedanib, and the Role of Next-Generation Phenomics in Drug Discovery
Sanjukta Dasgupta
OMICS A Journal of Integrative Biology (2025) Vol. 29, Iss. 3, pp. 87-95
Closed Access
Airway and cardiovascular remodeling in chronic obstructive pulmonary disease (COPD) as a target for transient receptor potential ankyrin 1 (TRPA1) channel modulators
Natalia Kocot, Elżbieta Pękala, Paulina Koczurkiewicz, et al.
Bioorganic Chemistry (2025) Vol. 158, pp. 108301-108301
Closed Access
Pirfenidone Delivery by Blow‐Molded PCL Nanofiber Mat to Reduce Collagen Synthesis by Fibroblasts
Maximilian Zernic, Maryo Kohen, Faruk Örge, et al.
Journal of Biomedical Materials Research Part A (2025) Vol. 113, Iss. 3
Open Access
Inhibition of Transglutaminase 2 by a Selective Small Molecule Inhibitor Reduces Fibrosis and Improves Pulmonary Function in a Bleomycin Mouse Model
Zejing Wang, Sriniwas Sriram, Cynthia Ugwoke, et al.
Cells (2025) Vol. 14, Iss. 7, pp. 497-497
Open Access
Fibrotic Pulmonary Sarcoidosis—From Pathogenesis to Management
Ewa Łyżwa, Jacek Wakuliński, Monika Szturmowicz, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2381-2381
Open Access
The Role of the Extracellular Matrix in Cancer Prevention
Stuart G. Baker, Edward R. Sauter
Cancers (2025) Vol. 17, Iss. 9, pp. 1491-1491
Open Access
Animal models of silicosis: fishing for new therapeutic targets and treatments
Alicia Martínez‐López, Sergio Candel, Sylwia D. Tyrkalska
European Respiratory Review (2023) Vol. 32, Iss. 169, pp. 230078-230078
Open Access | Times Cited: 9
Use of pirfenidone in fibrotic interstitial lung diseases and beyond: a review
Mingfeng Han, Qijia Liu, Zhe Ji, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Influenza, SARS-CoV-2, and Their Impact on Chronic Lung Diseases and Fibrosis
Sourabh Soni, Laura Antonescu, Kaylin Ro, et al.
American Journal Of Pathology (2024) Vol. 194, Iss. 10, pp. 1807-1822
Closed Access | Times Cited: 2
Integrating mechanical cues with engineered platforms to explore cardiopulmonary development and disease
Donia W Ahmed, Madeline K. Eiken, Samuel J. DePalma, et al.
iScience (2023) Vol. 26, Iss. 12, pp. 108472-108472
Open Access | Times Cited: 6
Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension
Dalia Dhia Hadi, Mohammed Dheyaa Marsool Marsool, Ali Dheyaa Marsool Marsool, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 11
Open Access | Times Cited: 5
The Plastic Interplay between Lung Regeneration Phenomena and Fibrotic Evolution: Current Challenges and Novel Therapeutic Perspectives
Sara Lettieri, F Bertuccio, Lucia Del Frate, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 547-547
Open Access | Times Cited: 5
Electrospun Fibers Loaded with Pirfenidone: An Innovative Approach for Scar Modulation in Complex Wounds
Erika Maria Tottoli, Laura Benedetti, Federica Riva, et al.
Polymers (2023) Vol. 15, Iss. 20, pp. 4045-4045
Open Access | Times Cited: 4
Peptidyl arginine deiminase-4 inhibitor ameliorates pulmonary fibrosis through positive regulation of developmental endothelial locus-1
Biswajit Panda, Alfiya Momin, Geetanjali Devabattula, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112861-112861
Closed Access | Times Cited: 1
Validated UV-Spectrophotometric Method for Pirfenidone Estimation in Bulk Drug, Marketed Tablet, and Nanoparticle Formulation
Kiran Dudhat, Janki Goswami, Harsha Patel
Pharmaceutical Chemistry Journal (2024) Vol. 58, Iss. 4, pp. 698-704
Closed Access | Times Cited: 1
Modeling the profibrotic microenvironment in vitro: model validation
Olga Grigorieva, Nataliya Basalova, Uliana Dyachkova, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 733, pp. 150574-150574
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top